Sharper definitions, blurred lines: The clinical aftermath of the revised antiphospholipid syndrome criteria
HemaSphere · 2026-03 · 10 (3)
DOI: 10.1002/hem3.70326 ↗Kurz gefasst
Editorial in der Zeitschrift HemaSphere, online erschienen am 22.03.2026. Verfasst von Lauren E Merz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Department of Medicine University of Michigan Ann Arbor Michigan United States. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Hematology/Oncology, Department of Medicine University of Michigan Ann Arbor Michigan United States.
- Division of Hematology/Oncology, Department of Medicine Mass General Brigham Boston Massachusetts United States.
ORCID-Profile: Lauren E Merz
Zitieren
APA
Merz, L. E., & Fogerty, A. E. (2026). Sharper definitions, blurred lines: The clinical aftermath of the revised antiphospholipid syndrome criteria. HemaSphere, 10(3). https://doi.org/10.1002/hem3.70326
Vancouver
Merz LE, Fogerty AE. Sharper definitions, blurred lines: The clinical aftermath of the revised antiphospholipid syndrome criteria. HemaSphere. 2026;10(3). doi:10.1002/hem3.70326
BibTeX
@article{Merz2026,
author = {Merz, Lauren E and Fogerty, Annemarie E},
title = {Sharper definitions, blurred lines: The clinical aftermath of the revised antiphospholipid syndrome criteria},
journal = {HemaSphere},
year = {2026},
volume = {10},
number = {3},
doi = {10.1002/hem3.70326}
}
EUVIMED